Abstract:OBJECTIVE:To investigate the effect of atorvastatin on the expression of lectin- like oxLDL receptor 1 (LOX-1) and endothelial nitric oxide synthase (eNOS) in collateral vessels of hypercholesterolemic rats.METHODS:Forty male SD rats were randomized equally into 4 groups: femoral ligation group (L), hypercholesterolemia + femoral ligation group (HL), hypercholesterolemia+atorvastatin+femoral ligation group (AL), and hypercholesterolemia+normal saline+femoral ligation group (NL). The rats in the latter 3 groups were fed atherogenic diet for 8 weeks. At the end of the 8 weeks, the rats were subjected to femoral artery ligation with or without intraperitoneal injection of atorvastatin (AL group) or saline (NL group). Two weeks later, all the rats were euthanized and the expressions of LOX-1 and eNOS in the collateral vessels were detected with immunofluorescence assay. In the in vitro experiment, cultured human umbilical vein endothelial cells (HUVECs) were transfected with LOX-1 siRNA followed by treatment with oxLDL and/or atorvastatin. The expressions of LOX-1 and eNOS in the cells were detected with realtime PCR and Western blotting, and the cellular NO production was examined with Griess assay.RESULTS:The collateral vessels of rats with normal feeding expressed LOX-1, which was significantly increased in the collateral vessels of hypercholesterolemic rats; atorvastatin treatment significantly lowered LOX-1 expressions in the hypercholesterolemic rats. In normally fed rats, the growing collateral vessels exhibited strong eNOS expressions, which were lowered in hypercholesterolemic rats and enhanced after atorvastatin treatment. In the cell experiment, HUVECs with oxLDL treatment showed a high LOX-1 expression and a low eNOS expression, and atorvastatin treatment of the cells down-regulated LOX-1 and up-regulated eNOS expressions. Inhibition of LOX-1 mediated by a specific LOX-1 siRNA abolished the effect of oxLDL stimulation on eNOS expression in the cells.CONCLUSIONS:Both hypercholesterolemia and oxLDL can induce endothelial dysfunction and impair collateral vessel growth via the LOX-1/eNOS pathway in rats, and atorvastatin treatment can restore the LOX-1/eNOS pathway to promote the growth of the collateral vessels, suggesting the potential of atorvastatin as a therapeutic agent to promote repair of collateral vessel injuries in ischemic diseases.

Overexpression of LOX-1 in hepatocytes protects vascular smooth muscle cells from phenotype transformation and wire injury induced carotid neoatherosclerosis through ALOX15

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

siLOXL2 Inhibits Endothelial Inflammatory Response and EndMT Induced by ox-LDL

Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid

Targeting LOX‐1 in Atherosclerosis and Vasculopathy: Current Knowledge and Future Perspectives

Effect of Atorvastatin on LOX-1 and Enos Expression in Collateral Vessels of Hypercholesterolemic Rats

Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression

Abstract 1339: LOX-1 Ablation Reduces Atherosclerosis

Role of Ox-LDL and LOX-1 in Atherogenesis

Anti-Lox-1 Rescues Endothelial Function in Coronary Arterioles in Atherosclerotic Apo-E Knockout Mice

Role of Oxidized LDL Receptor in Endothelial Cellular Injury by Oxidized Low-Density Lipoprotein

Atractylenolide I restores HO-1 expression and inhibits Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in vitro

Gene inactivation of lysyl oxidase in smooth muscle cells reduces atherosclerosis burden and plaque calcification in hyperlipidemic mice

Selective inhibition of hepatic stellate cell and fibroblast-derived LOXL1 attenuates BDL- and Mdr2-/--induced cholestatic liver fibrosis

Progress in Lecin-Like Oxidized LDL Receptor-1 As a Novel Therapeutic Target in Atherosclerotic Cardiovascular Diseases

LOX-1 Deletion Decreases Collagen Accumulation in Atherosclerotic Plaque in Low-Density Lipoprotein Receptor Knockout Mice Fed a High-Cholesterol Diet

LOX-1 Abrogation Reduces Myocardial Ischemia-Reperfusion Injury in Mice.

Ox-LDL Plays Dual Effect in Modulating Expression of Inflammatory Molecles Through LOX-1 Pathway in Human Umbilical Vein Endothelial Cells

Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism

Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor